相关实验视频
Updated: Jul 21, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
带有左心室辅助装置的患者的门诊护理
1Department of Cardiothoracic Surgery, University of Münster, Münster, Germany. schmid@uni-muenster.de
Circulation
|November 24, 1999
概括
左心室辅助装置 (LVAD) 植入后的门诊护理对于心力衰竭患者来说是可行的. 门诊治疗期间严重并发症不常见,支持其使用.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭管理的管理
背景情况:
- 左心室辅助器件 (LVADs) 显著改善心力衰竭患者的生活质量.
- 这项研究报告了LVAD植入后的门诊护理经验.
研究的目的:
- 评估LVAD患者门诊治疗的可行性和安全性.
- 评估LVAD植入后接受门诊护理的患者的并发症率和再入院模式.
主要方法:
- 对46名用电驱动LVAD植入患者的分析.
- 专注于16名患者 (35%),在初次住院后接受了部分门诊治疗.
- 追踪住院时间,门诊护理时间和再接收数据.
主要成果:
- 16名患者在医院住院86天后,平均接受了74天的门诊护理.
- 在13例病例中,重新入院发生,主要是由于感染,血栓塞栓事件或设备故障.
- 观察到感染 (0.0066/天) 和血栓栓塞事件 (0.0066/天) 的发病率较低.
结论:
- 在LVAD植入后的门诊管理是一种可行的治疗策略.
- 与门诊LVAD护理相关的严重并发症并不常见.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

